It has been found that only around 30 percent of Medicare Advantage recipients use their OTC benefits, according to CHPA.

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced prices on 10 widely used, brand-name medications that are expensive and lack generic or biosimilar alternatives.

Most Medicare Advantage enrollees say the extra perks offered by their plans are important, but less than half are taking advantage, a new study finds.

The Centers for Medicare and Medicaid Services has confirmed the standard monthly premium will rise to $202.90 next year.

A higher Medicare Part B premium in 2026 could erode next year's cost-of-living adjustment for Social Security recipients, experts say.

Last week, it was announced that the cost of Medicare premiums would increase by 9.7% in 2026 for 67.6 million beneficiaries — 949,495 of whom live in Louisiana.

Recent data from KFF (a nonprofit formerly known as the Kaiser Family Foundation) shows that while monthly premiums are dropping for many stand-alone drug plans, beneficiaries will have fewer options to choose from — and some expensive medications will cost significantly more.